HPVC2019-058 Pharmaceutical Products and IV Fluids
Current Contract
Description
Contract for the provision of a range of pharmaceutical products and intravenous fluids to Victorian Public Health Services.Additional Information
Update: 9 November 2021.
Note the updated indicative timeline for HPVITS2019-058.007 – Pharmaceutical Products and IV Fluids Supplementary 007
Please note that this tender is now accessible via the HSV Procurement Portal.
Market Engagement Date: 25 October 2021 - 17 November 2021.
Announcement of outcome to suppliers: 17 December 2021*
Announcement of outcome to health services: 20 January 2022*
Contract Commencement Date: 31 January 2022
*Please note dates listed are indicative dates.
Title: HPVITS2019-058.007 Pharmaceutical Products and IV Fluids Supplementary 007.
Scope:
|
|
Subcategory name |
|
7.04 |
ACICLOVIR 250 MG/10 ML INJECTION AMPOULE/VIAL 10 ML |
|
7.05 |
ACICLOVIR 500 MG/20 ML INJECTION AMPOULE/VIAL 20 ML |
|
20.02 |
AMBRISENTAN 5 MG TABLET 30 |
|
20.01 |
AMBRISENTAN 10 MG TABLET 30 |
|
71.02 |
BUSULFAN 60 MG/10 ML INJECTION, AMPOULE/VIAL 10 ML |
|
528.01 |
DARUNAVIR 600 MG TABLET 60 |
|
528.02 |
DARUNAVIR 800 MG TABLET 30 |
|
532.01 |
DASATINIB 20 MG TABLET 60 |
|
532.02 |
DASATINIB 50 MG TABLET 60 |
|
532.03 |
DASATINIB 70 MG TABLET 60 |
|
532.04 |
DASATINIB 100 MG TABLET 30 |
|
127.01 |
DEXAMETHASONE PHOSPHATE 4 MG/ML INJECTION, AMPOULE/VIAL 1 ML |
|
533.01 |
EVEROLIMUS 0.25 MG TABLET 60 |
|
533.02 |
EVEROLIMUS 0.5 MG TABLET 60 |
|
533.03 |
EVEROLIMUS 0.75 MG TABLET 60 |
|
533.04 |
EVEROLIMUS 1 MG TABLET 60 |
|
523.05 |
IMATINIB 100 MG TABLET/CAPSULE 60 (Gastrointestinal Stromal Tumour (GIST) indication) |
|
523.06 |
IMATINIB 400 MG TABLET/CAPSULE 30 (Gastrointestinal Stromal Tumour (GIST) indication) |
|
361.01 |
OXYTOCIN 10 UNITS/ML INJECTION, AMPOULE/VIAL 1 ML |
|
365.01 |
PARACETAMOL 1G/100 ML INJECTION |
|
439.01 |
SEVOFLURANE 1 ML/ML INHALATION SOLUTION, BOTTLE 250 ML |
|
529.01 |
SUNITINIB 12.5 MG TABLET/CAPSULE |
|
529.02 |
SUNITINIB 25 MG TABLET/CAPSULE |
|
529.03 |
SUNITINIB 37.5 MG TABLET/CAPSULE |
|
529.04 |
SUNITINIB 50 MG TABLET/CAPSULE |
|
535.01 |
TRIENTINE DIHYDROCHLORIDE 250mg CAPSULE 100 |
|
513.02 |
ZOLEDRONIC ACID 4 MG/5 ML INJECTION, AMPOULE/VIAL 5 ML |
Since this tender has been released, please direct all correspondence through the HSV Procurement Portal.
For any difficulties accessing the HSV Procurement Portal, please contact helpdesk@healthsharevic.org.au for assistance.
Useful information:
1. To subscribe and receive contract update notifications, favourite this contract cabinet.
2. Review your account settings to ensure the notification frequency selected is adequate.
3. Information for Prospective Suppliers can be found on our website: https://healthsharevic.org.au/tenders-and-contracts/information-for-new-suppliers/prospective-suppliers/
Categories
Category 1 - Pharmaceutical ProductsCategory 50,000 - Intravenous Fluids
Category 60,000 - Parenteral Nutrition Solutions
Category 70,000 - Irrigating Solutions
Category 80,000 - Biopharmaceuticals
Category 90,000 – Therapeutic Group Approach